15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 8.1% per year over the past 5 years.
Net income has grown faster than revenue (23.4% vs 8.1% per year).
Operating margin has expanded, at 8.5% in the latest year.
Free cash flow has declined 3.9% per year over the past 5 years.
Financial health
The company holds more cash ($93M) than total debt ($40M).
Operating income covered interest expense 20× in the latest year.
Total debt is 0.2× EBITDA.
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 32.2% of earnings and 26.0% of free cash flow.
The dividend has grown 3.9% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$1.5B
$120M
0.0%
8.5%
11.2%
7.9%
$149M
$40M
$93M
2024
$1.3B
$102M
0.0%
6.9%
10.4%
6.7%
$80M
$137M
$76M
2023
$1.1B
$67M
0.0%
5.0%
7.4%
5.1%
$83M
$0
$107M
2022
$1.1B
$22M
0.0%
2.9%
2.6%
1.8%
-$21M
—
$59M
2021
$1.1B
$139M
0.0%
4.7%
15.3%
9.9%
$23M
—
$108M
2020
$1.0B
$42M
0.0%
4.7%
5.3%
3.1%
$181M
—
$147M
2019
$996M
$68M
0.0%
4.9%
8.8%
5.3%
$74M
$10M
$50M
2018
$980M
$59M
0.0%
5.7%
8.0%
5.5%
$69M
$55M
$43M
2017
$964M
$56M
0.0%
5.6%
8.0%
5.1%
$62M
$100M
$59M
2016
$924M
$51M
0.0%
6.6%
7.5%
4.6%
$28M
$120M
$26M
2015
—
$53M
—
—
8.4%
5.1%
$25M
$120M
$38M
2014
—
$53M
—
—
7.3%
5.0%
$22M
$10M
$70M
2013
—
$65M
—
—
9.4%
6.6%
$59M
$10M
$82M
2012
—
$59M
—
—
9.0%
6.4%
$42M
$10M
$67M
2011
—
$65M
—
—
10.7%
7.5%
$59M
$10M
$61M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$408M
$40M
0.0%
12.0%
3.6%
2.6%
$31M
$0
$39M
Mar '26
$382M
$36M
0.0%
8.4%
3.3%
2.4%
$53M
$0
$86M
Dec '25
$387M
$25M
0.0%
8.6%
2.3%
1.6%
$6M
$40M
$93M
Sep '25
$383M
$39M
0.0%
7.9%
3.7%
2.5%
$56M
$73M
$131M
Jun '25
$375M
$24M
0.0%
9.1%
2.3%
1.5%
$53M
$110M
$111M
Mar '25
$374M
$32M
0.0%
8.2%
3.2%
2.1%
$33M
$134M
$90M
Dec '24
$369M
$6M
0.0%
7.8%
0.6%
0.4%
$5M
$137M
$76M
Sep '24
$340M
$43M
0.0%
6.7%
4.4%
2.7%
$29M
$147M
$85M
Jun '24
$301M
$27M
0.0%
7.5%
2.8%
2.0%
$43M
—
$136M
Mar '24
$297M
$26M
0.0%
5.3%
2.8%
2.0%
$4M
—
$94M
Dec '23
$301M
$28M
0.0%
6.7%
3.1%
2.2%
$17M
$0
$107M
Sep '23
$288M
$10M
0.0%
4.5%
1.2%
0.8%
$26M
—
$100M
Jun '23
$283M
$16M
0.0%
4.9%
1.8%
1.3%
$33M
—
$78M
Mar '23
$270M
$12M
0.0%
3.7%
1.3%
0.9%
$7M
—
$46M
Dec '22
$265M
$6M
0.0%
3.4%
0.7%
0.5%
$6M
—
$59M
Sep '22
$271M
-$2M
0.0%
1.5%
-0.3%
-0.2%
-$10M
—
$45M
Jun '22
$271M
$3M
0.0%
1.7%
0.4%
0.2%
$18M
—
$76M
Mar '22
$279M
$15M
0.0%
5.1%
1.7%
1.1%
-$36M
—
$57M
Dec '21
$283M
$16M
0.0%
3.2%
1.7%
1.1%
$2M
—
$108M
Sep '21
$277M
-$3M
0.0%
4.6%
-0.4%
-0.2%
-$6M
—
$112M
Valuation over time
How the market has priced NHC against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 40.5× (Mar '23) to 28.9× (Sep '26).
The price-to-sales ratio has risen from 0.8× (Mar '23) to 2.3× (Sep '26).
The dividend yield has fallen from 3.8% (Mar '23) to 1.1% (Sep '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is NHC growing its revenue and profit?
Over the past 5 years, National Healthcare Corp's revenue has grown 8.1% per year, and net income grown 23.4% per year. These are computed facts, not advice.
How much debt does NHC have?
As of FY2025, National Healthcare Corp reported $40M of total debt against $93M of cash; operating income covered interest expense 20×.
What is NHC's profit margin?
In FY2025, gross margin was —, operating margin 8.5%, and net margin 7.9%.
What is NHC's P/E ratio?
As of Sep '26, National Healthcare Corp traded at a price-to-earnings ratio of about 28.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.